Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe

  • Mena, Marisa|||0000-0003-2163-892X
  • Frias-Gomez, Jon|||0000-0002-0366-676X
  • Taberna, Miren|||0000-0002-2446-186X
  • Quirós, Beatriz|||0000-0002-6187-3732
  • Marquez, Sandra
  • Clavero, Omar|||0000-0001-9721-6382
  • Baena, Antoni.|||0000-0001-9221-8784
  • Lloveras, Belen|||0000-0001-8659-5241
  • Alejo, María
  • León i Vintró, Xavier|||0000-0001-6286-630X
  • García, Jacinto Montero
  • Mesia, Ricard|||0000-0002-3785-3563
  • Bermejo, Josep Oriol|||0000-0002-8581-9415
  • Bonfill Abella, Teresa|||0000-0003-2775-0293
  • Aguilà, Antón
  • Guix, Marta|||0000-0002-2143-0697
  • Hijano, Rafael|||0000-0001-6787-5440
  • Pavón, Miguel Ángel|||0000-0003-3677-5329
  • Torres, Montserrat A.
  • Tous, Sara|||0000-0002-5423-7092
  • Clèries, Ramon|||0000-0002-3637-4747
  • Alemany, Laia|||0000-0003-0945-6015
The incidence of human papillomavirus (HPV)-related oropharyngeal cancer is increasing in some regions. Nevertheless, the epidemiology of this disease has not been extensively investigated in southern Europe. We conducted a retrospective cohort study of patients diagnosed with primary oropharyngeal cancer from 1991 to 2016. Cancer tissues underwent histopathological evaluation, DNA quality control, HPV-DNA detection and p16 immunohistochemistry. Data were collected from medical records. Factors associated with HPV positivity and time trends were evaluated with multivariable Bayesian models. The adjusted prevalence of HPV-related cases in 864 patients with a valid HPV-DNA result was 9.7%, with HPV-DNA/p16 double positivity being considered. HPV-related oropharyngeal cancer was likely to occur in non-smokers and non-drinkers, to be located in the tonsil or diagnosed at advanced stages. Time-trend analysis showed an increasing risk of HPV-related oropharyngeal cancer in the most recent periods (5-year period increase of 30%). This increase was highest and with a clear increasing trend only in the most recent years (2012-2016). The prevalence of HPV-related oropharyngeal cancer started to sharply increase in the most recent years in our setting, as occurred two decades ago in areas where most oropharyngeal cancer cases are currently HPV-related. Our results provide a comprehensive assessment of the epidemiological landscape of HPV-related oropharyngeal cancer in a region of southern Europe.